Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Change in Receivables (2022 - 2025)

Envoy Medical's Change in Receivables history spans 4 years, with the latest figure at -$8000.0 for Q3 2025.

  • For Q3 2025, Change in Receivables rose 96.77% year-over-year to -$8000.0; the TTM value through Sep 2025 reached $109000.0, up 402.78%, while the annual FY2024 figure was -$32000.0, 118.18% down from the prior year.
  • Change in Receivables for Q3 2025 was -$8000.0 at Envoy Medical, down from $1000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $248000.0 in Q2 2024 and bottomed at -$248000.0 in Q3 2024.
  • The 4-year median for Change in Receivables is $2500.0 (2025), against an average of $7083.3.
  • The largest YoY upside for Change in Receivables was 490.48% in 2024 against a maximum downside of 559.26% in 2024.
  • A 4-year view of Change in Receivables shows it stood at -$56000.0 in 2022, then soared by 292.86% to $108000.0 in 2023, then grew by 3.7% to $112000.0 in 2024, then tumbled by 107.14% to -$8000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Change in Receivables are -$8000.0 (Q3 2025), $1000.0 (Q2 2025), and $4000.0 (Q1 2025).